Clinical Trial

Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

Study acronym: Venox-23
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings. This study will be conducted in Spain (multicentric), multicentric and data will be collected prospectively.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-17.
Trial Details
NCT Number NCT06790368
Lead Sponsor Inmunotek S.L.
Conditions Allergy, Insect Venom, Allergy Insect Stinging, Insect Sting Allergy
Enrollment 80 participants
Start Date 2025-01-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-01